收藏切换
Pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment
收藏切换
Guo-dong LYU, Xiao-dong SUN, Yuan-yuan LI, Sha-sha LIU, A-jiao WANG
World Clinical Drug | 2018, 39(9) : 625 - 629
Less
收藏切换
World Clinical Drug | 2018, 39(9): 625-629
• Article •
Pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment
Full
Guo-dong LYU, Xiao-dong SUN, Yuan-yuan LI, Sha-sha LIU, A-jiao WANG
Affiliations
  • Department of Pharmacy, Langfang People's Hospital, Langfang 065000, China
Published: 2018-09-10 doi: 10.13683/j.wph.2018.09.010
Outline
收藏切换
Objective

To investigate the pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment.

Methods

A total of 90 patients with type 2 diabetes mellitus, who were admitted to our hospital from January 2013 to June 2017, were divided into diabetes mellitus with renal impairment group (n=60) and diabetes mellitus with normal renal function group (n=30). Both groups were intravenously administrated with safflower yellow injection (100 mg safflower yellow was diluted with 250 ml of 0.9% sodium chloride solution). HPLC was used to detect hydroxysafflower yellow A before and after administration 5, 10, 20, 30, 40 min and 1, 1.5, 2, 3, 4, 5, 6, 8, 10 and 12 h in two groups. According to the blood concentration, the Cmax, t1/2α, t1/2β, Vd, CL and AUC were calculated. The blood and plasma viscosity of all patients were measured.

Results

Compared with the diabetes mellitus with normal renal function group, the whole blood viscosity and plasma viscosity of the diabetes mellitus with renal impairment group were higher (P<0.01). Compared with the diabetes mellitus with normal renal function group, the hydroxysafflower yellow A in the diabetes mellitus with renal impairment group at each time point after administration was higher (P<0.05). Compared with the diabetes mellitus with normal renal function, the Cmax, AUC and t1/2β were higher, and the t1/2α, Vd, and CL were decreased in the diabetes mellitus with renal impairment group (P<0.05, P<0.01).

Conclusion

The pharmacokinetics indexes (distribution and transportation) of safflower yellow in diabetes mellitus patients with renal impairment are changed and different from those patients without renal impairment.

safflower yellow  /  diabetes mellitus  /  renal function  /  pharmacokinetics
吕国栋, 孙晓东, 李媛媛, 刘莎莎, 王阿娇. 红花黄色素在糖尿病合并肾功能受损患者中的药物代谢动力学研究. 世界临床药物, 2018 , 39 (9) : 625 -629 . DOI: 10.13683/j.wph.2018.09.010
Guo-dong LYU, Xiao-dong SUN, Yuan-yuan LI, Sha-sha LIU, A-jiao WANG. Pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment[J]. World Clinical Drug, 2018 , 39 (9) : 625 -629 . DOI: 10.13683/j.wph.2018.09.010
Year 2018 volume 39 Issue 9
12
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.09.010
  • Receive Date:2018-03-10
  • Online Date:2026-11-18
  • Published:2018-09-10
Article Data
Affiliations
History
  • Received:2018-03-10
  • Revised:2018-04-16
Funding
Affiliations
    Department of Pharmacy, Langfang People's Hospital, Langfang 065000, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.09.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT